Research Articles | Page 18 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress Jul 2023 Expert Review of Anticancer Therapies Myelodysplastic Syndromes (MDS)
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies Mar 2024 Expert Opinion on Biological Therapy Myelodysplastic Syndromes (MDS)
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review Jul 2023 Experimental Hematology & Oncology Myelodysplastic Syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro May 2020 Experimental Hematology Myelodysplastic Syndromes (MDS)
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International PNH Registry Jul 2020 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab Dec 2020 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clonal selection in therapy related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment Jan 2020 European Journal of Haematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes Jul 2023 European Journal of Haematology Myelodysplastic Syndromes (MDS)
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real-world retrospective study Jun 2023 European Journal of Haematology Aplastic Anemia